Target Price | $7.00 |
Price | $0.98 |
Potential |
611.60%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Iterum Therapeutics Plc 2026 .
The average Iterum Therapeutics Plc target price is $7.00.
This is
611.60%
register free of charge
$9.00
814.91%
register free of charge
$5.00
408.29%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Iterum Therapeutics Plc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Iterum Therapeutics Plc stock has an average upside potential 2026 of
611.60%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.26 | -0.21 |
56.85% | 83.33% | |
P/E | negative | |
EV/Sales | 12.58 |
1 Analysts have issued a Iterum Therapeutics Plc forecast for earnings per share. The average Iterum Therapeutics Plc EPS is
This results in the following potential growth metrics and future valuations:
Iterum Therapeutics Plc...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.